Preferred Label : Hypobetalipoproteinemia, familial, 2;
Symbol : FHBL2;
CISMeF acronym : FHBL2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hypolipidemia, familial, combined;
Description : Hypobetalipoproteinemia (HBL) is defined as permanently low levels, below the 5th
percentile of sex- and age-matched individuals in the population, of apolipoprotein
B (apoB), total cholesterol, and low-density lipoprotein (LDL) cholesterol; the lipid
profile in FHBL2 includes low HDL cholesterol as well. HBL can result from environmental
factors such as a strict vegetarian diet, or can be secondary to certain diseases
such as intestinal fat malabsorption, chronic pancreatitis, severe liver disease,
malnutrition, or hyperthyroidism. Heritable primary causes of HBL include chylomicron
retention disease (CMRD; 246700), abetalipoproteinemia (200100), and familial hypobetalipoproteinemia
(FHBL) (summary by Martin-Campos et al., 2012). For a discussion of genetic heterogeneity
of familial hypobetalipoproteinemia, see FHBL1 (615558).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the angiopoietin-like-3 gene (ANGPTL3, 604774.0001);
Laboratory abnormalities : Near-complete absence of VLDL peak on density gradient ultracentrifugation (in some
patients); Marked hypobetalipoproteinemia; Low LDL cholesterol; Low apolipoprotein; Marked hypoalphalipoproteinemia (in some patients); Low to very low HDL cholesterol; Low triglycerides;
Prefixed ID : #605019;
Origin ID : 605019;
UMLS CUI : C1857970;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)